Defining Trajectories of Response in Psoriasis Patients Treated with Biologic Therapies
Br J Dermatol, 2021.
Geifman N, Azadbakht N, Zeng J, Wilkinson T, Dand N, Buchan I, Stocken D, Di Meglio P, Warren RB, Barker JN; Reynolds NJ, Barnes MR, Smith CH, Griffiths CEM, Peek N; BADBIR Study Group, on behalf of the PSORT Consortium.
Read publication: Br J Dermatol 2021
Related
Biosimilars for the Treatment of Psoriasis A Systematic Review of Clinical Trials and Observational ...
Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic ...
Risk of Major Cardiovascular Events in Patients With Psoriasis Receiving Biologic Therapies: A Prosp...
0 Comments